Humana Inc. (NYSE:HUM) Shares Acquired by Meeder Advisory Services Inc.

Meeder Advisory Services Inc. lifted its holdings in shares of Humana Inc. (NYSE:HUM) by 9.8% in the second quarter, HoldingsChannel reports. The firm owned 1,499 shares of the insurance provider’s stock after acquiring an additional 134 shares during the period. Meeder Advisory Services Inc.’s holdings in Humana were worth $560,000 at the end of the most recent reporting period.

Other institutional investors have also recently modified their holdings of the company. CarsonAllaria Wealth Management Ltd. raised its holdings in shares of Humana by 111.4% in the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after acquiring an additional 39 shares during the last quarter. Private Wealth Management Group LLC acquired a new position in Humana in the 4th quarter valued at about $32,000. Hantz Financial Services Inc. purchased a new position in Humana in the 2nd quarter valued at about $35,000. Family Firm Inc. acquired a new stake in shares of Humana during the 2nd quarter worth about $37,000. Finally, Riverview Trust Co purchased a new stake in shares of Humana during the second quarter worth about $44,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on HUM shares. TD Cowen upped their price objective on shares of Humana from $396.00 to $407.00 and gave the company a “buy” rating in a research note on Wednesday, July 24th. Baird R W raised Humana to a “hold” rating in a research report on Thursday, May 30th. Royal Bank of Canada increased their target price on Humana from $385.00 to $400.00 and gave the stock an “outperform” rating in a research report on Thursday, September 5th. Robert W. Baird started coverage on Humana in a research note on Thursday, May 30th. They issued a “neutral” rating and a $374.00 price target on the stock. Finally, JPMorgan Chase & Co. upped their price objective on shares of Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a research note on Wednesday, August 21st. Thirteen analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to data from MarketBeat.com, Humana presently has an average rating of “Hold” and an average target price of $398.70.

Humana Trading Down 0.9 %

NYSE:HUM opened at $321.56 on Friday. The business’s 50-day moving average is $364.11 and its two-hundred day moving average is $346.85. The firm has a market capitalization of $38.72 billion, a PE ratio of 20.02, a price-to-earnings-growth ratio of 2.56 and a beta of 0.50. Humana Inc. has a 12 month low of $298.61 and a 12 month high of $530.54. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.66 and a quick ratio of 1.66.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, beating the consensus estimate of $5.89 by $1.07. The business had revenue of $29.54 billion for the quarter, compared to the consensus estimate of $28.52 billion. Humana had a return on equity of 16.12% and a net margin of 1.53%. The company’s revenue was up 10.4% on a year-over-year basis. During the same period last year, the business posted $8.94 EPS. Research analysts predict that Humana Inc. will post 16 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Monday, September 30th. This represents a $3.54 annualized dividend and a dividend yield of 1.10%. Humana’s dividend payout ratio (DPR) is presently 22.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.